Interferon alpha-2a in combination therapies for the treatment of chronic hepatitis C in prior non-responders to interferon monotherapy

被引：0
|
作者：
Salmeron, J
Diago, M
Andrade, R
Perez, R
Sola, R
Romero, M
De La Mata, M
Granados, R
Torrente, V
Aguilar, J
Planas, R
Perez-Moreno, J
Casanovas, T
机构：
[1] Univ Hosp, Liver Unit, Granada, Spain
[2] Gen Hosp, Liver Unit, Valencia, Spain
[3] Hosp V De La Victoria, Liver Unit, Malaga, Spain
[4] Hosp Cent De Asturias, Liver Unit, Oviedo, Spain
[5] Hosp del Mar, Liver Unit, Barcelona, Spain
[6] Nuestra Senora De Valme, Liver Unit, Seville, Spain
[7] Hosp Reina Sofia, Liver Unit, Cordoba, Spain
[8] Hosp Dr Legrin, Liver Unit, Las Palmas Gran Canaria, Spain
[9] Hosp San Joan, Liver Unit, Tarragona, Spain
[10] Hosp Virgen Del Rocio, Liver Unit, Seville, Spain
来源：
JOURNAL OF HEPATOLOGY | 2003年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
580
引用
收藏
页码：168 / 168
页数：1
相关论文
共 50 条
  • [41] Treatment with interferon alpha-2a in patients with hepatitis C and hemophilia
    Zimmermann, R
    Huth-Kühne, A
    Lages, P
    Kallinowski, B
    33RD HEMOPHILIA SYMPOSIUM: HAMBURG 2002, 2004, : 167 - 172
  • [42] A controlled study of amantadine monotherapy vs. amantadine combined with interferon-α in chronic hepatitis C patients non-responders to interferon-α.
    El-Zayadi, A
    Selim, O
    Shawky, S
    Moustafa, H
    El-Taweel, A
    HEPATOLOGY, 1998, 28 (04) : 473A - 473A
  • [43] Cyclic and periodic interferon treatment with n.interferon β plus HLBI is effective for non-responders with chronic hepatitis C.
    Kishida, Y
    Naitoh, M
    Katayama, K
    Kashiwagi, T
    Hayashi, N
    Kinoshita, M
    HEPATOLOGY, 1999, 30 (04) : 617A - 617A
  • [44] Autoimmune Hepatitis Triggered by Treatment With Pegylated Interferon alpha-2a and Ribavirin for Chronic Hepatitis C
    Rathi, Chetan
    Pipaliya, Nirav
    Choksi, Dhaval
    Parikh, Pathik
    Ingle, Meghraj
    Sawant, Prabha
    ACG CASE REPORTS JOURNAL, 2015, 2 (04): : 247 - 249
  • [45] Predictive factors of a beneficial response to combination therapy of chronic hepatitis C in non-responders or relapsers to previous interferon treatment.
    Akarca, US
    Sayiner, A
    Ersoz, G
    Gunsar, F
    Ozacar, T
    Batur, Y
    HEPATOLOGY, 1999, 30 (04) : 631A - 631A
  • [46] Interferon alpha2b (IFN 2b) plus riboflavin (RIBA) for the treatment of chronic hepatitis C in prior interferon (IFN) non-responders (NR): Interim results of a community trial
    Lewis, JH
    Gallagher, JE
    Gibbs, L
    GASTROENTEROLOGY, 1998, 114 (04) : A1288 - A1288
  • [47] Retreatment of hepatitis C interferon non-responders with larger doses of interferon with and without phlebotomy
    VanThiel, DH
    Friedlander, L
    Molloy, PJ
    Kania, RJ
    Fagiuoli, S
    Wright, HI
    Gasbarrini, A
    Caraceni, P
    HEPATO-GASTROENTEROLOGY, 1996, 43 (12) : 1557 - 1561
  • [48] High-dose induction with interferon alpha 2b is safe and efficacious in interferon relapsers and non-responders with chronic hepatitis C.
    Ganger, CD
    Conjeevaram, H
    Wiley, T
    Flamm, S
    O'Riordan, K
    GASTROENTEROLOGY, 1998, 114 (04) : A1244 - A1244
  • [49] Combination treatment of interferon alpha-2b and ribavirin in comparison to interferon monotherapy in treatment of chronic hepatitis C genotype 4 patients
    El-Zayadi, A
    Selim, O
    Haddad, S
    Simmonds, P
    Hamdy, H
    Badran, HM
    Shawky, S
    ITALIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1999, 31 (06): : 472 - 475
  • [50] Interferon alfa plus ribavirin in chronic hepatitis C relapsers and non-responders to previous interferon alfa course
    Salmerón, J
    Vivaldi, RM
    De la Mata, M
    Romero, M
    Moreno, JP
    Aguilar, J
    Palacios, A
    Nogueras, F
    Vignote, M
    Alcántara, R
    Suarez, E
    Andrade, R
    Rodriguez, L
    Sanchez, H
    Quintero, D
    JOURNAL OF HEPATOLOGY, 2000, 32 : 185 - 185
12345